Intraerythrocyte antioxidant enzyme activities in migraine and tension-type headaches

Journal of the Chinese Medical Association

Volumn 67, Issue 6, 2004, Pages 263-267

  Bolayir, Ertugrul ^a   Celik, Kenan ^a   Kugu, Nesim ^a   Yilmaz, Abdulkerim ^a   Topaktas, Suat ^a   Bakir, Sevtap ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Antioxidant enzyme activities; Migraine with aura; Migraine without aura; Tension headache

Indexed keywords

ANTIOXIDANT; CATALASE; EDETIC ACID; ERYTHROCYTE ENZYME; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MIGRAINE; PATHOGENESIS; PATHOPHYSIOLOGY; RANK SUM TEST; TENSION HEADACHE;

ADULT; CATALASE; ENZYMES; ERYTHROCYTES; GLUTATHIONE PEROXIDASE; HUMANS; MIGRAINE DISORDERS; SUPEROXIDE DISMUTASE; TENSION-TYPE HEADACHE;

EID: 4344570956     PISSN: 17264901     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;(suppl 7):1-96.
2. Olesen J, Peer TF-Hansen, K. Michael AW. The Headaches. Philadelphia: Lippincott-Williams and Wilkins, 2000;227-33.
3. Hassinger HJ, Semenchuk EM, O'Brien WH. Cardiovascular responses to pain and stress in migraine. Headache 1999; 39:605-15.
4. Kowa H, Yasui K, Takeshima T, Urakami K, Sakai F, Nakashima K. The homozygous C677T mutation in the methylentetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000;96:762-4.
5. Tozzi E, Tozzi-Ciancarelli MG, Di Massimo C, Mascioli A, Angelini R, de Matteis F. Platelet responsiveness in migrainous children during headache-free period. Headache 1996;36:95-9.
6. Schlesinger RH. Homocysteine levels in migraine patients. Cephalalgia 1997;17:46.
7. Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and treatment. N Engl J Med 2002;346:257-70.
8. Fahr S, Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 1992;32:804-12.
9. Clemens MR, Walker HD. Lipid peroxidation in erythrocytes. Chem Phys Lipids 1987;45:251-68.
10. Halliwel B. Oxidant and human disease: some new concepts. Faseb J 1987;1:358-64.
11. Shimomura T, Kowa H, Nahano T, Kitano A, Marukawa H, Urakami K, Takahashi K. Platelet superoxide dismutase in migraine and tension- type headache. Cephalalgia 1994;14: 215-8.
12. Ikeda Y, Jimbo H, Shimazu M, Satoh K. Sumatriptan scavenges superoxide, hydroxyl, and nitric oxide radicals: in vitro electron spin resonance study. Headache 2002;42:888-92.
13. Choudhuri R, Cui I, Yong C. Cortical spreading depression and gene regulation: relevance to migraine. Ann Neurol 2002; 51:499-506.
14. Silberstein SD, Lipton RB, Goadsby PJ. Headache in Clinical Practice. Oxford: Isis Medical Media Ltd. 1998;101-14.
15. Leone M, Grazzi L, Mantia LL, Bussone G. Flunarizine in migraine: a mini review. Headache 1991;31:388-91.
16. Fairbanks VF, Klee GG. Measurement of hemoglobin concentration in whole blood on plasma. In: Autor Tick NW, ed. Fundamentals of clinical chemistry. Philadelphia: W.B. Saunders Company, 1987;803-4.
17. Podozasy JJ, Wei R. Reduction of iodonitrotetrazolium violet by superoxide radicals. Biochem Biophys Rec Com 1988;150: 1294-301.
18. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-69.
19. Prohaska JR, Oh SH, Hoekstra WG, Ganther HE. Glutathione peroxidase inhibition by cyanide and release of selenium. Biochem Biophys Res Com 1977;74:64-71.
20. Krause RJ, Gauther HE. Reaction of cyanide with glutathione peroxidase. Biochem Biophys Res Com 1980;96:1116-22.
21. Aebi H. Catalase in vitro: methods in enzymology. In: Autor Colowick SP, Kaplan NO, eds. Florida: Academic Press, 1984;121-6.
22. Yüksel A, Cengiz M, Seven M, Ulutin T. Changes in the antioxidant system in epileptic children receiving antiepileptic drugs: 2 team prospective studies. J Child Neurol 2001;16: 603-6.
23. Verotti A, Basciani F, Trotta D, Pomilio MP, Morgese G, Chiarelli F. Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapies. Epilepsy Res 2002;48:71-5.
24. Cengiz M, Yüksel A, Seven A. The effects of carbamazepine and valproic acid on the erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children. Pharmacol Res 2000;41:423-5.
25. Percy ME, Dalton AJ, Markovic VD, Mclachlan DR, Hummel JT, Rusk AC, Andrews DF. Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer's disease. Am J Med Genet 1990;35:459-67.
26. Josberger JA, Richardson JS. Oxygen free radicals and brain dysfunction. Int J Neurosci 1991;57:1-17.
27. Lohr BJ. Oxigen radicals and neuropsychiatric illness: some speculations. Arc Gen Psychiatry 1991;48:1097-104.
28. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: An overview. In: Abelson JN, Simson MI, eds. Methods in Enzymology. San Diego, California: Academic Press, 1990;1-85.
29. Lunec J. Free radicals: their involvement in disease processes. Ann Clin Biochem 1990;27:173-82.
30. Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroǧlu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001;64:43-51.
31. Cao Y, Welch KMA, Aurora S, Vikingstad EM. Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol 1999;56:548-54.
32. Fridovich I. Superoxide dismutase. Ann Rev Biochem 1975; 44:147-59.
33. Malmgren R, Hasselmark L. The platelet and the neuron: 2 cells in focus in migraine. Cephalalgia 1988;8:7-24.
34. Welch KMA. Pathogenesis of migraine: seminars in Neurology. New York: Thieme Medical Publishers, 1997;335-41.
35. Schoenen J. Cortical electrophysiology in migraine and possible pathogenetic implications. Clin Neurosci 1998;5:10-7.
36. Lauritzen M, Olesen J. Regional Cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain 1984;107:447-61.
37. Andersen AR, Friberg L, Olsen TS, Olesen J. Delayed hyperemia following computed tomographic demonstration. Arch Neurol 1988;45:154-9.
38. Kaplan RD, Solomon GD, Diamond S, Freitag FG. The role of MRI in the evaluation of a migraine population: preliminary data. Headache 1987;27:315-8.
39. Olsen TS, Lassen NA. Blood and vascular reactivity during attacks of classic migraine limitations of the Xe-133 intraarterial technique. Headache 1989;29:15-20.
40. Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MB. Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. J Neurochem 1989;52:515-20.
41. Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, Marsden CD. A selective increase in particulate superoxide dismutase activity in Parkinsonian substantia nigra. J Neurochem 1989;53:692-7.
42. Halliwell B, Gutteridge JMC. Oxygen radicals and the nervous system. TINS 1985;8:22-9.
43. Couch JR, Hassanein R. Headache as a risk factor in atherosclerosis-related diseases. Headache 1989;29:49-54.
44. D'Eufemia P, Finocchiaro R, Lendvai D, Celli M, Viozzi L, Troiani P, Turri E, Giardini O. Erythrocyte and plasma levels of glutamate and aspartate in children affected by migraine. Cephalalgia 1997;17:652-7.